NCT07261956Recruiting
Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia
Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia
Source: ClinicalTrials.gov · Last updated 3 Dec 2025
Brief summary (registry, in English)
This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a serious complication called pulmonary edema, especially after delivery. The study will be a prospective, longitudinal observational study with a diagnostic validation component. It will involve patients with a diagnosis of severe preeclampsia who meet specific inclusion criteria. Each participant will undergo a clinical exam and a lung ultrasound, which will assess eight zones of the lungs. The total number of B-lines-a sign of interstitial edema-will be documented. Data will be collected at three key times: upon admission, in the immediate postpartum period (within 24 hours of delivery), and 7-10 days postpartum. The results from the LUS will be compared to clinical signs like shortness of breath, rapid breathing, crackling sounds in the lungs, and oxygen saturation levels. The expected impact of this research is to provide evidence that LUS is a valuable, non-invasive, and accessible tool for the early detection of pulmonary congestion in patients with severe preeclampsia. This could lead to improved clinical decision-making and a reduction in maternal respiratory complications.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 202 (estimated)
- First submitted
- 24 Aug 2025
- Start date
- 25 Aug 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Saint Thomas Hospital, Panama
- NCT number
- NCT07261956
What you commit to
- Study type: Interventional
- Planned participants: 202
- From 25 Aug 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic lung disease.
- Known heart disease.
Other
- Diagnosis of lung edema at admission
- Body mass index \> 40
- Need for immediate delivery
Who the study is looking for
- Preeclampsia with severe features.
- Gestational age 24 weeks - 41 weeks.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Saint Thomas Hospital Coordinator of this site? Confirm its status | Panama City | Panama | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.